XENE · Xenon Pharmaceuticals Inc. · Documents
$36.47
+1.39 (+3.96%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$3.51B
Shares
96.84M
Volume · Oct 20
521.24K
Avg daily vol (3M)
1.42M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-03-08 | — | |
| 8-K | — | 2024-02-29 | — | |
| 10-K | — | 2024-02-29 | 2023-12-31 | |
| 8-K | — | 2023-11-30 | 2023-11-29 | |
| 8-K | — | 2023-11-27 | — | |
| 8-K | — | 2023-11-09 | — | |
| 10-Q | — | 2023-11-08 | 2023-09-30 | |
| 8-K | — | 2023-11-08 | — | |
| 8-K | — | 2023-08-09 | — | |
| 10-Q | — | 2023-08-09 | 2023-06-30 | |
| 8-K | — | 2023-08-08 | — | |
| 8-K | — | 2023-06-02 | 2023-06-01 | |
| 8-K | — | 2023-05-09 | — | |
| 10-Q | — | 2023-05-09 | 2023-03-31 | |
| DEF 14A | — | 2023-04-27 | — | |
| ARS | — | 2023-04-27 | 2022-12-31 | |
| 8-K | — | 2023-03-14 | 2023-03-10 | |
| 8-K | — | 2023-03-08 | — | |
| 8-K | — | 2023-03-01 | — | |
| 10-K | — | 2023-03-01 | 2022-12-31 | |
| 10-Q | — | 2022-11-08 | 2022-09-30 | |
| 8-K | — | 2022-11-08 | — | |
| 8-K | — | 2022-11-07 | — | |
| 10-Q | — | 2022-08-09 | 2022-06-30 | |
| 8-K | — | 2022-08-09 | — | |
| 8-K | — | 2022-06-23 | 2022-06-22 | |
| 8-K | — | 2022-06-21 | — | |
| 8-K | — | 2022-06-02 | 2022-06-01 | |
| 8-K | — | 2022-05-10 | — | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| DEF 14A | — | 2022-04-28 | 2022-06-01 | |
| 8-K | — | 2022-03-22 | 2022-03-16 | |
| 8-K | — | 2022-03-10 | 2022-03-09 | |
| 10-K | — | 2022-03-01 | 2021-12-31 | |
| 8-K | — | 2022-03-01 | — | |
| 8-K | — | 2022-03-01 | — | |
| 8-K | — | 2022-01-12 | 2022-01-11 | |
| 8-K | — | 2021-12-01 | 2021-11-24 | |
| 10-Q | — | 2021-11-10 | 2021-09-30 | |
| 8-K | — | 2021-11-10 | — | |
| 8-K | — | 2021-10-06 | 2021-10-05 | |
| S-3ASR | — | 2021-10-04 | — | |
| 8-K | — | 2021-10-04 | — | |
| 8-K | — | 2021-09-08 | — | |
| 8-K | — | 2021-08-23 | — | |
| 8-K | — | 2021-08-11 | — | |
| 10-Q | — | 2021-08-11 | 2021-06-30 | |
| 8-K | — | 2021-06-03 | — | |
| 10-Q | — | 2021-05-11 | 2021-03-31 | |
| 8-K | — | 2021-05-11 | — |
Showing 51–100 of 128 filings
Key facts
CIK
1582313
CUSIP
98420N105
13F (30d)
15 filings
15 filers
Visit website
Investor relations